Putra, O. N., Faizah, A. K., Nurrahman, N. W., & Hardiyono. (2020). Chloroquine: An Old to be Repurposed Drug For COVID-19 Infection (Risk and Benefit). Pharmaceutical Sciences and Research, 7(4), 49-56. doi:10.7454/psr.v7i4.1076

Chloroquine: An Old to be Repurposed Drug For COVID-19 Infection (Risk and Benefit)

Smith College

Engineers are currently synthesizing new medications to treat patients with COVID-19.

Pharmaceutical Engineering for COVID-19

Previously used drugs approved by the FDA have been repurposed in order to be tested against COVID-19. However, clinical trials are underway for several anti-malarial drugs in order to test their effects against the disease.

In silico approaches that are currently used for drug repurposing, including molecular docking, molecular dynamics, and computational chemistry, constitute valuable tools to aid preclinical and clinical studies of nanomaterials directed for disease treatment. 


Learn Before

Related

Learn After